FindTrial
Sign In

recombinant fowlpox GM-CSF vaccine adjuvant

BIOLOGICAL3 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Adenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the PancreasAdenocarcinoma of the RectumAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerBladder AdenocarcinomaBladder Squamous Cell Carcinoma

Phase 1

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
CompletedNCT00028496
National Cancer Institute (NCI)Adenocarcinoma of the Colon, Adenocarcinoma of the Gallbladder, Adenocarcinoma of the Pancreas +39
Start: 2001-11-30Updated: 2013-01-25
Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy
TerminatedNCT00072137
National Cancer Institute (NCI)Bladder Adenocarcinoma, Bladder Squamous Cell Carcinoma, Bladder Urothelial Carcinoma +5
Start: 2003-10-31End: 2010-11-30Updated: 2014-12-23

Unknown Phase

Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery
CompletedNCT00091039
National Cancer Institute (NCI)Lung Cancer
Start: 2004-08-31End: 2006-02-28Updated: 2013-06-20